Trifork Group AG
40/2024・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
40/2024・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
Company announcement no. 40 / 2024
Schindellegi, Switzerland – 6 December 2024
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by a person or entity closely associated with a person discharging managerial responsibilities in Trifork.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Jørn Larsen | |
| 2. | Reason for the notification | ||
| a) | Position/status | CEO | |
| b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Trifork Group AG | |
| b) | LEI | 8945004BYZKXPESTBL36 | |
| 4.1 | Details of the transaction(s) | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares ISIN CH1111227810 | |
| b) | Nature of the transaction | Transfer of shares to Blackbird II ApS, a company 100% owned and controlled by Jørn Larsen | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 80.00 | 95,000 | ||
| d) | Aggregated information
| Aggregated volume: 95,000 Price: DKK 80.00 Total value: DKK 7,600,000.00 | |
| e) | Date of the transaction | 5 December 2024 | |
| f) | Place of the transaction | OTC off-exchange | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Blackbird II ApS | |
| 2. | Reason for the notification | ||
| a) | Position/status | Closely associated person to Jørn Larsen, CEO of Trifork Group AG | |
| b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Trifork Group AG | |
| b) | LEI | 8945004BYZKXPESTBL36 | |
| 4.1 | Details of the transaction(s) | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares ISIN CH1111227810 | |
| b) | Nature of the transaction | Transfer of shares from Jørn Larsen’s private shareholding | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 80.00 | 95,000 | ||
| d) | Aggregated information
| Aggregated volume: 95,000 Price: DKK 80.00 Total value: DKK 7,600,000.00 | |
| e) | Date of the transaction | 5 December 2024 | |
| f) | Place of the transaction | OTC off-exchange | |
For more information, please contact:
Frederik Svanholm, Group Investment Director & Head of IR
frsv@trifork.com, +41 79 357 7317
About Trifork Group
Trifork is a pioneering global technology partner, empowering enterprise and public sector customers with innovative solutions. With 1,278 professionals across 76 business units in 15 countries, Trifork delivers expertise in inspiring, building, and running advanced software solutions across diverse sectors, including public administration, healthcare, manufacturing, logistics, energy, financial services, retail, and real estate. Trifork Labs, the Group’s R&D hub, drives innovation by investing in and developing synergistic and high-potential technology companies. Trifork Group AG is a publicly listed company on Nasdaq Copenhagen. Learn more at trifork.com.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma25.12.2024 17:40:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma25.12.2024 17:30:00 CET | Press release
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
VERUM MESSENGER LTD25.12.2024 09:00:00 CET | Press release
Verum Ecosystem: The Future of Digital Communication and Finance
Made In Nature24.12.2024 22:54:25 CET | Pressemeddelelse
Made in Nature, økologiske gaver under juletræet: En kærlig gestus over for mennesker og planeten
Vastned Belgium24.12.2024 14:00:00 CET | Press release
Vastned Belgium strengthens its portfolio in Louvain and Namur with the acquisition of Gevaert NV
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom